Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cally Roper

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Lancet (London, England)|April 11, 2003
Antifolate antimalarial resistance in southeast Africa: a population-based analysisCally Roper, Richard Pearce, Barry Bredenkamp, et al.
Tropical Medicine & International Health : TM & IH|September 2, 2015
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysisR Matthew Chico, Jorge Cano, Cono Ariti, et al.
Malaria Research and Treatment|February 21, 2012
Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspectiveAllen Malisa, Richard Pearce, Benezeth Mutayoba, et al.
Malaria Journal|July 7, 2010
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamineAllen L Malisa, Richard J Pearce, Salim Abdulla, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 13, 2017
Corrigendum to "Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes" [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174-180]Ana Rita Gomes, Matt Ravenhall, Ernest Diez Benavente, et al.
The Journal of Infectious Diseases|May 13, 2008
Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest UgandaCaroline Lynch, Richard Pearce, Hirva Pota, et al.
Malaria Journal|July 11, 2014
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in TanzaniaReginald A Kavishe, Petro Paulo, Robert D Kaaya, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2010
Origin and dissemination across the Colombian Andes mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparumVladimir Corredor, Claribel Murillo, Diego F Echeverry, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 5, 2017
Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmesAna Rita Gomes, Matt Ravenhall, Ernest Diez Benavente, et al.
Malaria Journal|April 19, 2017
Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based studyCaroline A Lynch, Richard Pearce, Hirva Pota, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Lancet (London, England)|April 11, 2003
Antifolate antimalarial resistance in southeast Africa: a population-based analysisCally Roper, Richard Pearce, Barry Bredenkamp, et al.
Tropical Medicine & International Health : TM & IH|September 2, 2015
Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysisR Matthew Chico, Jorge Cano, Cono Ariti, et al.
Malaria Research and Treatment|February 21, 2012
Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspectiveAllen Malisa, Richard Pearce, Benezeth Mutayoba, et al.
Malaria Journal|July 7, 2010
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamineAllen L Malisa, Richard J Pearce, Salim Abdulla, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 13, 2017
Corrigendum to "Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes" [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174-180]Ana Rita Gomes, Matt Ravenhall, Ernest Diez Benavente, et al.
The Journal of Infectious Diseases|May 13, 2008
Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest UgandaCaroline Lynch, Richard Pearce, Hirva Pota, et al.
Malaria Journal|July 11, 2014
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in TanzaniaReginald A Kavishe, Petro Paulo, Robert D Kaaya, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2010
Origin and dissemination across the Colombian Andes mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparumVladimir Corredor, Claribel Murillo, Diego F Echeverry, et al.
International Journal for Parasitology. Drugs and Drug Resistance|April 5, 2017
Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmesAna Rita Gomes, Matt Ravenhall, Ernest Diez Benavente, et al.
Malaria Journal|April 19, 2017
Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based studyCaroline A Lynch, Richard Pearce, Hirva Pota, et al.
Pageof 9